POSEIDA THERAPEUTICS INC (PSTX) Stock News

PSTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Poseida Therapeutics, Inc. Is Fair to Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PWOD, RVNC, B, PSTX on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates B, ZUO, PSTX on Behalf of Shareholders

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Pactiv Evergreen Inc. (Nasdaq – PTVE), Enterprise Bancorp, Inc. (Nasdaq Global Select Market – EBTC), The Interpublic Group of Companies, Inc. (NYSE – IPG), Poseida

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PSTX, AVTE, GATO on Behalf of Shareholders

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Poseida Therapeutics, Inc. (Nasdaq – PSTX), Gatos Silver, Inc. (NYSE - GATO), Micropac Industries, Inc. (OTC - MPAD), Aerovate Therapeutics, Inc. (Nasdaq - AVTE)

10 Health Care Stocks With Whale Alerts In Today's Session

POSEIDA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Poseida Therapeutics, Inc. - PSTX

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PSTX, ZUO, MNTX on Behalf of Shareholders

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Poseida Therapeutics, Inc. (Nasdaq – PSTX), Air Transport Services Group, Inc. (Nasdaq– ATSG), Micropac Industries, Inc. (OTC - MPAD), Aerovate Therapeutics, Inc.

Shareholder Alert: Ademi LLP investigates whether Poseida Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders

PSTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Poseida Therapeutics, Inc. Is Fair to Shareholders

Where Poseida Therapeutics Stands With Analysts

MaxCyte Appoints Cynthia Collins to its Board of Directors

PSTX Stock Earnings: Poseida Therapeutics Beats EPS, Beats Revenue for Q2 2024

PSTX stock results show that Poseida Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

PSTX Stock Earnings: Poseida Therapeutics Beats EPS, Beats Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Poseida Therapeutics (NASDAQ:PSTX) just reported results for the second quarter...